Here's how to advocate for Wegovy coverage: Ask HR: "Does our plan cover GLP-1 medications for weight management
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
But to get to this point, it took a lot of basic science, which is focused on learning about the world
However, while these mechanistic insights are promising, the translation into robust clinical outcomes remains limited, and current evidence is largely derived from in vitro and animal models (123125)
These medications work by reducing appetite and slowing digestion, which leads to significant weight loss in a relatively short period